India Takes Steps To End Branded Drug Name Confusion
This article was originally published in PharmAsia News
Executive Summary
Indian authorities plan to establish a licensing board to approve names applied to branded drugs to end confusion over medicines with similar names. The Drug Controller General of India approves drugs marketed in the country, but names come under the authority of the Trade Marks Act and are licensed on the state level. The new licensing authority would be part of a broader plan to move manufacturing authority from the state to the federal level and a central agency. The chemical and health ministries already have given their approval to the proposed rearrangement. (Click here for more